Transplantation: Steroid Use in HCV-infected Liver Transplant Recipients
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Roche B, Samuel D
. Risk factors for hepatitis C recurrence after liver transplantation. J Viral Hepat. 2007; 14 Suppl 1:89-96.
DOI: 10.1111/j.1365-2893.2007.00920.x.
View
2.
Berenguer M, Royuela A, Zamora J
. Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis. Liver Transpl. 2006; 13(1):21-9.
DOI: 10.1002/lt.21035.
View
3.
Klintmalm G, Washburn W, Rudich S, Heffron T, Teperman L, Fasola C
. Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study. Liver Transpl. 2007; 13(11):1521-31.
DOI: 10.1002/lt.21182.
View
4.
Lerut J, Bonaccorsi-Riani E, Finet P, Gianello P
. Minimization of steroids in liver transplantation. Transpl Int. 2009; 22(1):2-19.
DOI: 10.1111/j.1432-2277.2008.00758.x.
View
5.
Lake J
. Immunosuppression and outcomes of patients transplanted for hepatitis C. J Hepatol. 2006; 44(4):627-9.
DOI: 10.1016/j.jhep.2006.02.002.
View